Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score52
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Srinivas Akkaraju
26 Oct 2026
Director
Buy indirect
97,982
$41.59
$4.08M
Srinivas Akkaraju
26 Oct 2026
Director
Buy indirect
48,988
$41.59
$2.04M
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
1,000
$41.82
$41.82K
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
500
$41.82
$20.91K
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
94,000
$41.31
$3.88M
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
47,000
$41.31
$1.94M
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
4,403
$40.97
$180.39K
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
12,400
$40.18
$498.23K
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
12,796
$39.31
$503.01K
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
13,748
$39.52
$543.32K
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
80,863
$38.68
$3.13M
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
18,414
$37.89
$697.71K
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
319,700
$37.42
$11.96M
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
56,703
$36.74
$2.08M
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
11,011
$35.61
$392.10K
Samsara BioCapital GP, LLC
16 Oct 2023
10% owner
Buy indirect
2,189,781
$6.85
$15.00M
Srinivas Akkaraju
16 Oct 2023
Director
Buy indirect
2,189,781
$6.85
$15.00M
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
10,150
$8.55
$86.74K
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
2,189,781
$6.85
$15.00M
Invus Public Equities, L.P.
28 Apr 2023
10% owner
Buy
31,557
$6.43
$202.85K
Invus Public Equities, L.P.
5 Jan 2023
10% owner
Buy
48,774
$9.33
$455.09K
Invus Public Equities, L.P.
25 Oct 2022
10% owner
Buy
130,265
$8.04
$1.05M
Invus Public Equities, L.P.
4 Oct 2022
10% owner
Buy
66,000
$7.89
$520.76K
Invus Public Equities, L.P.
3 Oct 2022
10% owner
Buy
33,971
$7.03
$238.79K
Amir Nashat
22 Jun 2022
Director
Buy indirect
66,142
$4.90
$324.10K
Amir Nashat
22 Jun 2022
Director
Buy indirect
1,131,850
$4.90
$5.55M
Timothy A Springer
29 May 2018
Director
Buy
71,428
$14.00
$999.99K
International S.C.A. Artal
29 May 2018
10% owner
Buy indirect
450,000
$14.00
$6.30M
Amir Nashat
29 May 2018
Director
Buy indirect
7,887
$14.00
$110.42K
Amir Nashat
29 May 2018
Director
Buy indirect
134,970
$14.00
$1.89M
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
7,887
$14.00
$110.42K
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
134,970
$14.00
$1.89M

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,452,736
Sales filed before the plan box existed 7
History held since 31 May 2018